Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week

Summary

This article is general stock market commentary about Nasdaq, Dow Jones, and Russell 2000 performance with a focus on technology and software sectors. It contains no biotech or pharmaceutical news, clinical trial data, FDA decisions, or company-specific announcements relevant to the biotech/pharma industry.